William Grossman Md Phd Email Address

Senior Vice President Oncology Clinical Development, Therapeutic Area Head

Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.

Dr. Grossman is Senior Vice President, Oncology Therapeutic Area Head at Gilead Sciences and currently sits on the Board of Directors for Pionyr Immunotherapeutics and Tizona Therapeutics, and the Oncology Advisory Board for Bryologyx Inc. Dr. Grossman is committed to advancing Gilead’s research and development programs to create possibilities for people with overlooked, underserved, and difficult-to-treat cancers. Dr. Grossman has extensive experience leading large successful global clinical organizations and has overseen more 50 clinical trials spanning Phase 1 through Phase 3, resulting in the approval of several oncology and immunology marketed products. Dr. Grossman has extensive industry experience. Prior to his role at Gilead, he previously served as Chief Medical Officer at both Arcus Biosciences and Bellicum Pharmaceuticals, where he was responsible for clinical development, regulatory affairs, clinical operations, and medical affairs organizations. He has also served as the Global Group Medical Director for Cancer Immunotherapy at Genentech, where he led the clinical development of TECENTRIQ® in gastrointestinal cancers and of cancer immunotherapy combinations across all solid tumor types. Before joining Genentech, Dr. Grossman the Head of the U.S. & Global medical affairs oncology franchise at AbbVie, and held increasing leadership positions in research, clinical development, and medical affairs at Merck & Co., Baxter Healthcare and Biothera Inc. working on anti-cancer vaccines, immunomodulatory agents, small molecules and biologics for oncology. Prior to joining the industry, Dr. Grossman held various positions with the Medical College of Wisconsin and the Children’s Hospital of Wisconsin and was the Founder and Medical Director of the Clinical Immunodiagnostic and Research Laboratory, Professor for Microbiology and Genetics, and Director of the Hematology/Oncology/Bone Marrow Transplant Division for the Immunodeficiency Transplant Program. Dr. Grossman earned his M.D. and Ph.D. (Immunology) degrees from Washington University School of Medicine and completed his advanced medical and research training in the Divisions of Pediatrics and Medicine at the Washington University School of Medicine.